(Q73690442)
Statements
Treatment of post-transplant lymphoproliferative disease with induction chemotherapy followed by haploidentical peripheral blood stem cell transplantation and Rituximab (English)
Skoda-Smith S
Douglas VK
Mehta P
Graham-Pole J